Brookdale Senior Living earnings jump to profit despite lower revenue

Brookdale Senior Living (BKD) reported second quarter 2026 results on 10 August, shifting from a net loss a year ago to a net profit, even as sales and total revenue were lower.

Brookdale Senior Living's recent earnings swing to profit comes as the share price has eased in the short term, with a 7 day share price return of an 11.11% decline and a 30 day share price return of a 15.79% decline. However, the 1 year total shareholder return of 72.91% and 3 year total shareholder return of about 3x suggest momentum has been building over a longer horizon despite recent volatility around the US$12.64 level and the earnings update on 10 August 2026.

If Brookdale's move back into profit has you reassessing opportunities across healthcare, it can help to widen your watchlist with other growth stories in the space through 42 healthcare AI stocks.

Brookdale Senior Living has moved back into profit while the share price has slipped and analyst estimates sit well above the current US$12.64 level. This raises the question of where a fair value range really falls across that spread.

Most Popular Narrative: 25.6% Undervalued

Brookdale Senior Living's most followed narrative anchors fair value at $17.00 versus the last close at $12.64, which puts a clear gap between narrative expectations and the current market price.

Brookdale's aging facility portfolio and substantial deferred maintenance requirements will necessitate high capital expenditures in coming years, which will pressure free cash flow and could drive up debt, creating substantial headwinds for net earnings and overall return on invested capital.

Want to see how Brookdale Senior Living is still priced for upside despite those heavy capex and debt concerns? The core narrative leans on a rebuilt margin profile, steadier revenue growth and a future earnings multiple that is usually reserved for companies with very strong profit trajectories.

Result: Fair Value of $17.00 (UNDERVALUED)

However, Brookdale Senior Living still faces risks if rising labor costs or heavier regulation erode margins and could challenge the $17.00 fair value narrative.

Another View on Brookdale Senior Living’s Valuation

The SWS DCF model presents a very different perspective compared with the $17.00 fair value narrative. On this view, Brookdale Senior Living at $12.64 trades above an estimated future cash flow value of $8.48, which screens as overvalued and raises a simple question: Which risk matters more to you, earnings trajectories or cash generation assumptions?

For a closer look at how this cash flow view is built, and where the key inputs sit, Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Brookdale Senior Living for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 52 high quality undervalued stocks. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Next Steps

With Brookdale Senior Living sending mixed signals on value and risk, it helps to see the full picture for yourself before reacting to headlines. Take a closer look at the balance between potential upside and downside with 2 key rewards and 1 important warning sign

Looking for more Brookdale Senior Living style investment ideas?

If Brookdale Senior Living has sharpened your focus, do not stop here. Broaden your watchlist now so you are not chasing the next move late.

• Target outlier opportunities that combine quality with attractive pricing by scanning through 52 high quality undervalued stocks.
• Prioritise resilience and capital preservation by sorting companies through the 80 resilient stocks with low risk scores.
• Get ahead of the crowd by focusing on smaller companies with strong fundamentals using the screener containing 20 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.